Rodin Therapeutics Overview
- Year Founded
-
2013
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$950M
- Investors
-
1
Rodin Therapeutics General Information
Description
Developer of epigenetic drugs intended to be used for the treatment of cognitive disorders and diseases of the brain. The company's epigenetic drugs are harnessing the power of epigenetic regulation of neuronal function by HDAC complex modulation, enabling patients to restore synaptic function, health and survival in degenerative brain diseases.
Contact Information
Website
www.rodintherapeutics.comCorporate Office
- 300 Technology Square
- 8th Floor
- Cambridge, MA 02139
- United States
Corporate Office
- 300 Technology Square
- 8th Floor
- Cambridge, MA 02139
- United States
Rodin Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Merger/Acquisition | 25-Nov-2019 | $950M | Completed | Product Development | ||
| 5. Grant | 13-Nov-2017 | Completed | Product Development | |||
| 4. Later Stage VC (Series C) | 18-Sep-2017 | Completed | Product Development | |||
| 3. Early Stage VC (Series B) | 06-Jan-2016 | Completed | Startup | |||
| 2. Early Stage VC (Series A) | 29-May-2014 | $12.9M | $12.9M | Completed | Startup | |
| 1. Seed Round | 27-Jun-2013 | Completed | Startup |
Rodin Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A3 | ||||||||
| Series A2 | 1,649,147 | $0.000100 | 5% | $1.1 | $1.1 | 1x | $1.1 | 4.13% |
| Series A1 | 1,612,675 | $0.000100 | 5% | $1 | $1 | 1x | $1 | 4.04% |
Rodin Therapeutics Comparisons
Industry
Financing
Details
Rodin Therapeutics Competitors (81)
One of Rodin Therapeutics’s 81 competitors is CervoMed, a Formerly VC-backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CervoMed | Formerly VC-backed | Boston, MA | ||||
| Mighty Therapeutics | Private Equity-Backed | Needham, MA | ||||
| Aquinnah | Venture Capital-Backed | Cambridge, MA | ||||
| NeuroNascent | Venture Capital-Backed | Clarksville, MD | ||||
| Cognition Therapeutics | Formerly VC-backed | New York, NY |
Rodin Therapeutics Patents
Rodin Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2020014602-A1 | Bicyclic inhibitors of histone deacetylase | Inactive | 13-Jul-2018 | ||
| WO-2020014605-A1 | Inhibitors of histone deacetylase | Inactive | 13-Jul-2018 | ||
| AU-2018313094-A1 | Bicyclic inhibitors of histone deacetylase | Inactive | 07-Aug-2017 | ||
| WO-2019032528-A1 | Bicyclic inhibitors of histone deacetylase | Inactive | 07-Aug-2017 | ||
| WO-2019032528-A8 | Bicyclic inhibitors of histone deacetylase | Inactive | 07-Aug-2017 | A61K31/437 |
Rodin Therapeutics Former Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alzheimers Drug Discovery Foundation | Not-For-Profit Venture Capital | Minority | ||
| Atlas Venture | Venture Capital | Minority | ||
| Biogen | Corporation | Minority | ||
| GV | Corporate Venture Capital | Minority | ||
| Hatteras Venture Partners | Venture Capital | Minority |
Rodin Therapeutics FAQs
-
When was Rodin Therapeutics founded?
Rodin Therapeutics was founded in 2013.
-
Where is Rodin Therapeutics headquartered?
Rodin Therapeutics is headquartered in Cambridge, MA.
-
What industry is Rodin Therapeutics in?
Rodin Therapeutics’s primary industry is Drug Discovery.
-
Is Rodin Therapeutics a private or public company?
Rodin Therapeutics is a Private company.
-
What is the current valuation of Rodin Therapeutics?
The current valuation of Rodin Therapeutics is .
-
What is Rodin Therapeutics’s current revenue?
The current revenue for Rodin Therapeutics is .
-
How much funding has Rodin Therapeutics raised over time?
Rodin Therapeutics has raised $57.2M.
-
Who are Rodin Therapeutics’s investors?
Alzheimers Drug Discovery Foundation, Atlas Venture, Biogen, GV, and Hatteras Venture Partners are 5 of 11 investors who have invested in Rodin Therapeutics.
-
Who are Rodin Therapeutics’s competitors?
CervoMed, Mighty Therapeutics, Aquinnah, NeuroNascent, and Cognition Therapeutics are some of the 81 competitors of Rodin Therapeutics.
-
When was Rodin Therapeutics acquired?
Rodin Therapeutics was acquired on 25-Nov-2019.
-
Who acquired Rodin Therapeutics?
Rodin Therapeutics was acquired by Alkermes.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process